- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 138
Pulsalys sets forth accelerator for female researchers
Three Pulsalys businesses in healthcare and consumer feature in the first intake, run in partnership with local incubator Les Premières Aura.
Oct 1, 2020XY spells out $59m series B
Zhejiang University-backed optical chip maker XY Technology will put the series B cash to strengthening its capacity and product.
Oct 1, 2020Daily deal net: September 30, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Sep 30, 2020Inspiration Capital sparks $73m fund
Shanghai Jiao Tong University is among the limited partners in a $73m fund raised by Qiming spinoff Inspiration Capital.
Sep 30, 2020Mosa Meat starts cooking up series B
Bell Food Group and M Ventures have contributed to an initial $55m series B tranche for the cultured meat developer spun out of Maastricht University.
Sep 30, 2020OLV boosts revenues to $65m
Duke University's TTO processed a record number of patents and invention disclosures, and also reported growth at its digital innovations unit.
Sep 30, 2020UpShow entertains $14m series A
4490 Ventures, a VC firm aligned to University of Wisconsin-Madison, backed a series A extension intended to advance in-venue digital marketing technology company UpShow's product and recruitment plans.
Sep 30, 2020Wood swings to ETH Zurich executive
Vanessa Wood, a professor at ETH Zurich specialised in electrical engineering, will now also supervise the university's approach to knowledge transfer and corporate relations.
Sep 30, 2020Taysha rakes in $181m from public listing
UT Southwestern-founded Taysha Gene Therapies surpassed its goal after underwriters bought additional shares.
Sep 29, 2020Palladio fills palette with $20m
OUP has injected follow-on funding into Palladio, creators of a drug for autosomal dominant polycystic kidney disease.
Sep 29, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


